• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用方差分析理解深度学习模型参数对乳腺癌组织病理学分类的影响。

Understanding the Impact of Deep Learning Model Parameters on Breast Cancer Histopathological Classification Using ANOVA.

作者信息

Hernandez Nerea, Carrillo-Perez Francisco, Ortuño Francisco M, Rojas Ignacio, Valenzuela Olga

机构信息

Department of Computer Engineering, Automation and Robotics, University of Granada, 18071 Granada, Spain.

出版信息

Cancers (Basel). 2025 Apr 24;17(9):1425. doi: 10.3390/cancers17091425.

DOI:10.3390/cancers17091425
PMID:40361352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071027/
Abstract

UNLABELLED

Artificial intelligence (AI) has the potential to enhance clinical practice, particularly in the early and accurate diagnosis of diseases like breast cancer. However, for AI models to be effective in medical settings, they must not only be accurate but also interpretable and reliable. This study aims to analyze how variations in different model parameters affect the performance of a weakly supervised deep learning model used for breast cancer detection.

METHODS

In this work, we apply Analysis of Variance (ANOVA) to investigate how changes in different parameters impact the performance of the deep learning model. The model is built using attention mechanisms, which both perform classification and identify the most relevant regions in medical images, improving the interpretability of the model. ANOVA is used to determine the significance of each parameter in influencing the model's outcome, offering insights into the specific factors that drive its decision-making.

RESULTS

Our analysis reveals that certain parameters significantly affect the model's performance, with some configurations showing higher sensitivity and specificity than others. By using ANOVA, we identify the key factors that influence the model's ability to classify images correctly. This approach allows for a deeper understanding of how the model works and highlights areas where improvements can be made to enhance its reliability in clinical practice.

CONCLUSIONS

The study demonstrates that applying ANOVA to deep learning models in medical applications provides valuable insights into the parameters that influence performance. This analysis helps make AI models more interpretable and trustworthy, which is crucial for their adoption in real-world medical environments like breast cancer detection. Understanding these factors enables the development of more transparent and efficient AI tools for clinical use.

摘要

未标注

人工智能(AI)有潜力提升临床实践,尤其是在乳腺癌等疾病的早期准确诊断方面。然而,要使人工智能模型在医疗环境中有效,它们不仅必须准确,还必须具有可解释性和可靠性。本研究旨在分析不同模型参数的变化如何影响用于乳腺癌检测的弱监督深度学习模型的性能。

方法

在这项工作中,我们应用方差分析(ANOVA)来研究不同参数的变化如何影响深度学习模型的性能。该模型使用注意力机制构建,既能进行分类又能识别医学图像中最相关的区域,从而提高模型的可解释性。方差分析用于确定每个参数在影响模型结果方面的重要性,深入了解驱动其决策的具体因素。

结果

我们的分析表明,某些参数对模型性能有显著影响,一些配置比其他配置表现出更高的敏感性和特异性。通过使用方差分析,我们确定了影响模型正确分类图像能力的关键因素。这种方法有助于更深入地理解模型的工作方式,并突出可以改进的领域,以提高其在临床实践中的可靠性。

结论

该研究表明,将方差分析应用于医学应用中的深度学习模型,可为影响性能的参数提供有价值的见解。这种分析有助于使人工智能模型更具可解释性和可信度,这对于它们在乳腺癌检测等现实世界医疗环境中的应用至关重要。了解这些因素有助于开发更透明、高效的临床用人工智能工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/2d4c4f4398a0/cancers-17-01425-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/84288b7f05f6/cancers-17-01425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/5e838e8a2f50/cancers-17-01425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/4f66550fed57/cancers-17-01425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/4e01ca2f7f4b/cancers-17-01425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/234ea5f0ec4e/cancers-17-01425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/47d89e7bf100/cancers-17-01425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/7635921c300d/cancers-17-01425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/54e0bf2b8deb/cancers-17-01425-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/494d9be5dc90/cancers-17-01425-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/93bf9b43b53a/cancers-17-01425-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/22b119cf8efc/cancers-17-01425-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/cb48fe6970bf/cancers-17-01425-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/5a01a07cfe6f/cancers-17-01425-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/a215b5907892/cancers-17-01425-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/5244f5119e1a/cancers-17-01425-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/2c84068bdf00/cancers-17-01425-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/61fb6f2b8931/cancers-17-01425-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/2d4c4f4398a0/cancers-17-01425-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/84288b7f05f6/cancers-17-01425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/5e838e8a2f50/cancers-17-01425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/4f66550fed57/cancers-17-01425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/4e01ca2f7f4b/cancers-17-01425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/234ea5f0ec4e/cancers-17-01425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/47d89e7bf100/cancers-17-01425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/7635921c300d/cancers-17-01425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/54e0bf2b8deb/cancers-17-01425-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/494d9be5dc90/cancers-17-01425-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/93bf9b43b53a/cancers-17-01425-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/22b119cf8efc/cancers-17-01425-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/cb48fe6970bf/cancers-17-01425-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/5a01a07cfe6f/cancers-17-01425-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/a215b5907892/cancers-17-01425-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/5244f5119e1a/cancers-17-01425-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/2c84068bdf00/cancers-17-01425-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/61fb6f2b8931/cancers-17-01425-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3483/12071027/2d4c4f4398a0/cancers-17-01425-g018.jpg

相似文献

1
Understanding the Impact of Deep Learning Model Parameters on Breast Cancer Histopathological Classification Using ANOVA.使用方差分析理解深度学习模型参数对乳腺癌组织病理学分类的影响。
Cancers (Basel). 2025 Apr 24;17(9):1425. doi: 10.3390/cancers17091425.
2
Brain tumor segmentation and detection in MRI using convolutional neural networks and VGG16.使用卷积神经网络和VGG16在磁共振成像(MRI)中进行脑肿瘤分割与检测
Cancer Biomark. 2025 Mar;42(3):18758592241311184. doi: 10.1177/18758592241311184. Epub 2025 Apr 4.
3
ViT-MAENB7: An innovative breast cancer diagnosis model from 3D mammograms using advanced segmentation and classification process.基于先进分割和分类流程的 3D 乳腺 X 线摄影的乳腺癌诊断新模型:ViT-MAENB7。
Comput Methods Programs Biomed. 2024 Dec;257:108373. doi: 10.1016/j.cmpb.2024.108373. Epub 2024 Aug 23.
4
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.深度学习方法在自身免疫性大疱性疾病中的直接免疫荧光模式识别。
Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142.
5
Weakly supervised learning in thymoma histopathology classification: an interpretable approach.胸腺瘤组织病理学分类中的弱监督学习:一种可解释的方法。
Front Med (Lausanne). 2024 Dec 11;11:1501875. doi: 10.3389/fmed.2024.1501875. eCollection 2024.
6
Applied machine learning in intelligent systems: knowledge graph-enhanced ophthalmic contrastive learning with "clinical profile" prompts.智能系统中的应用机器学习:通过“临床概况”提示进行知识图谱增强的眼科对比学习
Front Artif Intell. 2025 Mar 12;8:1527010. doi: 10.3389/frai.2025.1527010. eCollection 2025.
7
Leveraging code-free deep learning for pill recognition in clinical settings: A multicenter, real-world study of performance across multiple platforms.利用无代码深度学习在临床环境中进行药丸识别:在多个平台上进行的多中心真实世界性能研究。
Artif Intell Med. 2024 Apr;150:102844. doi: 10.1016/j.artmed.2024.102844. Epub 2024 Mar 13.
8
ResViT FusionNet Model: An explainable AI-driven approach for automated grading of diabetic retinopathy in retinal images.ResViT融合网络模型:一种用于视网膜图像中糖尿病视网膜病变自动分级的可解释人工智能驱动方法。
Comput Biol Med. 2025 Mar;186:109656. doi: 10.1016/j.compbiomed.2025.109656. Epub 2025 Jan 16.
9
Deep convolutional neural network and IoT technology for healthcare.用于医疗保健的深度卷积神经网络和物联网技术。
Digit Health. 2024 Jan 17;10:20552076231220123. doi: 10.1177/20552076231220123. eCollection 2024 Jan-Dec.
10
An Explainable AI Paradigm for Alzheimer's Diagnosis Using Deep Transfer Learning.一种基于深度迁移学习的可解释人工智能阿尔茨海默病诊断范式。
Diagnostics (Basel). 2024 Feb 5;14(3):345. doi: 10.3390/diagnostics14030345.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Machine learning in computational histopathology: Challenges and opportunities.计算病理中的机器学习:挑战与机遇。
Genes Chromosomes Cancer. 2023 Sep;62(9):540-556. doi: 10.1002/gcc.23177. Epub 2023 Jun 14.
3
BRACS: A Dataset for BReAst Carcinoma Subtyping in H&E Histology Images.
BRACS:用于 H&E 组织学图像中乳腺癌分型的数据集。
Database (Oxford). 2022 Oct 17;2022. doi: 10.1093/database/baac093.
4
Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images.基于组织病理图像的多重实例学习对三阴性乳腺癌的生存预测。
Sci Rep. 2022 Aug 25;12(1):14527. doi: 10.1038/s41598-022-18647-1.
5
DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer.DeepSMILE:从结直肠癌和乳腺癌的 H&E 全切片图像中直接进行对比自监督预训练,有利于 MSI 和 HRD 分类。
Med Image Anal. 2022 Jul;79:102464. doi: 10.1016/j.media.2022.102464. Epub 2022 Apr 29.
6
Data-efficient and weakly supervised computational pathology on whole-slide images.基于全切片图像的数据高效和弱监督计算病理学。
Nat Biomed Eng. 2021 Jun;5(6):555-570. doi: 10.1038/s41551-020-00682-w. Epub 2021 Mar 1.
7
A multi-resolution model for histopathology image classification and localization with multiple instance learning.基于多实例学习的病理图像分类和定位的多分辨率模型。
Comput Biol Med. 2021 Apr;131:104253. doi: 10.1016/j.compbiomed.2021.104253. Epub 2021 Feb 10.
8
Artificial intelligence and computational pathology.人工智能与计算病理学。
Lab Invest. 2021 Apr;101(4):412-422. doi: 10.1038/s41374-020-00514-0. Epub 2021 Jan 16.
9
Digital Pathology: Advantages, Limitations and Emerging Perspectives.数字病理学:优势、局限性与新兴观点
J Clin Med. 2020 Nov 18;9(11):3697. doi: 10.3390/jcm9113697.
10
Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains.基于基础水平的 H&E 染色的深度学习辅助乳腺癌激素受体状态判定。
Nat Commun. 2020 Nov 16;11(1):5727. doi: 10.1038/s41467-020-19334-3.